Familial aggregation of blood pressure (BP) has been recognised for a long time and enquiry about family history, especially in parents, forms a standard part of our assessment of a hypertensive patient. To some extent, a positive response conditions our interpretation of the patient's BP and also provides a simple (although not necessarily true) explanation for the patient's condition that he/she can easily understand-'it runs in your genes'! How strong is the influence of a positive family history of hypertension? Two approaches have been used to analyse this. First, studies have looked at the effect of a family history on the risk of developing hypertension. [1] [2] [3] The most comprehensive analysis has been done by Hunt and colleagues in Utah. In a prospective study of 1482 adults, a positive family history (two first-degree relatives with hypertension) was associated with a 2.35-fold unadjusted and a 1.82-fold adjusted risk of hypertension. In a separate study of 94 292 persons, they investigated parameters that influenced this familial risk. Age of subject, number of affected relatives and the ages at which they developed hypertension all had significant effects. Risk was highest (4.1-fold for males, 5.0-fold for females) in young adults (20-39 years) when both parents were affected early (Ͻ55 years of age). The risk associated with a positive family history decreased rapidly and was not at all apparent, even with a strong family history, in subjects over the age of 60.
The alternative approach has been to directly quantify the effect of a positive family history on BP. Again several studies have shown that subjects with a positive history (variously defined) have higher BP than those without such a history. [4] [5] [6] [7] This is true for both clinic 4, 5 as well as ambulatory BP 6, 7 with group differences of between 3 and 13 mm Hg for systolic BP. Most of these studies have focused on relatively young subjects (Ͻ35 years) because of the view that familial factors are likely to act early. In this issue of the Journal of Human Hypertension Naruse et al report the impact of parental history on BP up to the age of 59 years. In a total of 591 men and women aged 20-59, recruited in three Japanese population samples as part of the INTERSALT study, they found higher clinic BP in participants with a parental history of hypertension compared to those without, in three out of four age-sex strata with differences between 3.3-6.8 mm Hg for systolic BP and 2.7-5.5 mm Hg for diastolic BP. The differences were observed despite several limitations of the study including: (i) the fact that the parental history was not directly ascertained but defined as reported by the subject, and the inaccuracy of this is well recognised; (ii) BP was only measured on one occasion; and (iii) a significantly greater proportion of those with a parental history were taking antihypertensive medication, although this was adjusted for. The findings therefore underscore the important impact of family history on BP. It is regrettable that the data could not be stratified either by number of parents affected or the age of onset of disease in them. Remarkably, the effect of parental history was stronger for persons aged 40-59 than those aged 20-39. This could reflect, as the authors discuss, an accumulative or amplifying effect of environmental factors on a genetic predisposition with time. However, the finding is somewhat at variance with the Utah data 3 showing a reduced effect of parental history on the risk of hypertension in older age groups. Further studies are required to look at this.
What, if any, are the implications of quantifying the impact of parental history on BP? The direct practical usefulness in managing individual patients is low as the mean values mask a range of effects which will vary according to underlying mechanisms and environmental interactions. However, I would concur with Naruse et al 8 that family history should be one of the factors taken into account when advising a subject about preventive measures. The main use that has been made of parental history has been to partition subjects (usually young) into groups with contrasting parental histories to identify features that may be aetiologically linked to hyper-tension. The premise is that those with a positive parental history are more prone to develop hypertension and investigating them in a 'pre-hypertensive' phase will distinguish features that are primary rather than secondary to the rise in BP. A plethora of studies have used this approach and a large number of differences have been documented between those with and those without hypertensive parents (some reviewed in Reference 9). I have always been intrigued by this approach and the sometimes striking differences that have been reported often with relatively small numbers in each group. The reason for the scepticism is two-fold. First, the predictive power of a positive family history is low. 3, 5, 10 The correlate of this is that many 'normotensive' parents will pass inherited factors predisposing their children to hypertension although they themselves do not manifest the condition. Thus many subjects in such studies will be mis-grouped in terms of their own risk of hypertension. In this context, Watt 5 has emphasised the importance of improving the predictive power by sampling offspring where parents are known to be both hypertensive (high group) or to both lie in the bottom quintile of BP distribution for their population (low group). Unfortunately such precision or indeed even direct information on parental BPs is lacking from many studies. 5, 9 Second, even if the predictive power was high, the underlying mechanism(s) in different families is likely to vary on the basis that the condition is polygenic. While this does not matter when one considers the final phenotype (BP), which will be raised because of the familial factor irrespective of the mechanism, it would dilute the ability to detect an intermediary phenotype. Yet, differences have been observed easily and sometimes more readily than the effect on BP. 5, 9 There are three possible explanations: (i) the intermediary phenotype being investigated lies on the final common pathway leading to raised BP (ie, it is also independent of the underlying mechanism). This may, for example, apply to structural changes and BP reactivity to stressors; 9 (ii) that there are only a few basic genetic mechanisms but with quite marked pleiotropic effects, explaining the association with the wide range of intermediary phenotypes. This explanation seems inherently unlikely but cannot be refuted at this stage, (iii) many of the associations are spurious either due to small numbers or some form of unrecognised selection bias. These possibilities need to be borne in mind when interpreting the results of such studies utilising a parental history to classify subjects.
